Barclays raised the firm’s price target on UiPath to $18 from $16 and keeps an Equal Weight rating on the shares. The analyst sees the company’s Q2 results as a “small positive to the underlying story,” with lower sentiment into the print creating a potential short squeeze for shares. UiPath’s profitability and cash flow continue to be the highlight and management’s tone around customer conversations seem to be improving, though questions remain on bookings and new logos, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on PATH:
- UiPath (NYSE:PATH): Analysts Issue Hold Ratings Despite Strong Q2 Results
- UiPath (NYSE:PATH) Soars on Impressive Q2 Numbers
- Uipath Inc Earnings Update: Did it Beat Estimate Forecasts?
- UiPath jumps 6% to $17.21 after Q2 earnings beat, guidance raise
- UiPath raises FY24 revenue view to $1.273B-$1.278B from $1.267B-$1.272B